Early Life and Education
George D. Yancopoulos was born in 1959 to Greek immigrant parents in the United States. He grew up in New York City and attended public schools, graduating as valedictorian from the Bronx High School of Science. He also graduated as valedictorian of Columbia College and then received his M.D. and Ph.D. in Biochemistry and Molecular Biophysics from Columbia University's College of Physicians & Surgeons in 1987.
Rise to Success
Yancopoulos launched his career in molecular immunology at Columbia University, under Dr. Fred Alt. In 1989, he co-founded Regeneron Pharmaceuticals with Leonard Schleifer. Together, they have grown Regeneron into a leading biotechnology company. Yancopoulos is the key driver of Regeneron's science-driven culture. His leadership has led to ten FDA-approved or authorized treatments and a promising pipeline.
Key Business Strategies
Yancopoulos's key strategy has been a focus on innovation and translating scientific discoveries into medicines. His team invented innovative technologies like the VelocImmune mouse, leading to blockbuster drugs such as EYLEA and Dupixent. Yancopoulos emphasizes a collaborative, team-based approach to science and the importance of hiring top talent.
Philanthropy
Yancopoulos is known for philanthropic efforts, particularly in education and healthcare. Regeneron, under his guidance, has been involved in initiatives that support patient access and scientific innovation. He also supports the Society for Science's science competitions. Regeneron's focus on STEM is part of its overall Corporate Responsibility strategy, which uses its unique knowledge and expertise for the benefit of society, the economy, and the environment.
